<scp>GPCR</scp>‐mediated<scp>EGF</scp>receptor transactivation regulates<scp>TRPV</scp>4 action in the vasculature

Abstract

We conclude that the GPCR potentiation of TRPV4 action and TRPV4-dependent Tx receptor activation are important regulators of vascular function and could be therapeutically targeted in vascular diseases.